HARVARD BIOSCIENCE INC - 8-K Filing
Harvard Bioscience's shareholders approved amendments on June 2, 2026, increasing authorized shares for its Amended and Restated 2021 Incentive Plan by 400,000 shares (totaling 1,046,520 available as of that date) and the Employee Stock Purchase Plan by 190,000 additional shares. The amendments were submitted for shareholder approval at its annual meeting. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $HBIO